ManiMNICF 98 Days Payable is 7.67 as of Feb. 2026, which is 11% below its 10-year median of 8.63. GuruFocus rates MNICF with a GF Score™ of 98/100 and a GF Value™ of $15.94. The stock has 6 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Mani ranks worse than 99.25% on this metric.
Mani's average Accounts Payable for the
three
months ended in Feb. 2026 was $1.5 Mil. Mani's Cost of Goods Sold for the
three
months ended in Feb. 2026 was $17.5 Mil.
Hence, Mani's Days Payable for the
three
months ended in Feb. 2026 was 7.67.
The historical rank and industry rank for Mani's Days Payable or its related term are showing as below:
MNICF'
s Days Payable Range Over the Past 10 Years
Min: 5.43 Med: 8.63 Max: 15.11
Current: 7.49
During the past 13 years, Mani's highest Days Payable was 15.11. The lowest was 5.43. And the median was 8.63.
MNICF's Days Payable is ranked worse than 99.25% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs MNICF: 7.49
Mani's Days Payable
increased
from Feb. 2025 (7.27) to Feb. 2026 (7.67).
It may suggest that Manidelayed paying its suppliers.
Mani Days Payable Related Terms
Mani Days Payable Historical Data
* Premium members only.
The historical data trend for Mani's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Mani's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mani Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Mani's Days Payable distribution charts can be found below:
* The bar in red indicates where Mani's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Mani's Days Payable for the fiscal year that ended in Aug. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mani (MNICF) has a Days Payable of 7.67 as of Feb. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Mani and its competitors. This is 11% below median its historical median of 8.63. Over the past decade, Mani's Days Payable has ranged from 5.43 to 15.11. According to the industry distribution chart, Mani ranks #789 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 99.2%.
Is Mani's Days Payable too high?
Mani's current Days Payable of 7.67 is 11% below median its 10-year median of 8.63. Over the past 10 years, this metric has ranged from a low of 5.43 to a high of 15.11. The Medical Devices & Instruments industry median Days Payable is 67.87. Mani's value of 7.67 is 88.7% below this industry median. Based on the distribution chart, Mani ranks #789 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Mani has a GF Score™ of 98/100, reflecting its overall financial health beyond just this single metric.
How does Mani's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Mani ranks #789 out of 795 companies for Days Payable. This places Mani in the lower half of its industry. The industry median Days Payable is 67.87. Mani's value of 7.67 is 88.7% below this benchmark. Historically, Mani's own Days Payable has ranged from 5.43 to 15.11 over the past decade. While the company's 10-year median is 8.63 vs. the industry median of 67.87, Mani has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mani's current Days Payable of 7.67 is 88.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Mani and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mani's current Days Payable is 7.67, which is 11% below median its own 10-year median of 8.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mani stock overvalued right now?
Mani (MNICF) has a current Days Payable of 7.67. The stock's GF Value™ is $15.94, compared to a current price of $12.82 — trading 19.6% below its estimated fair value. The current Days Payable is 7.67, which is 11% below median its 10-year median of 8.63 and 88.7% below the Medical Devices & Instruments industry median of 67.87. Mani's overall GF Score™ is 98/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Mani (MNICF), the current Days Payable is 7.67 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mani (MNICF) Overvalued in 2026?
Based on GuruFocus' analysis, Mani stock appears to be undervalued.
The current stock price of $12.82 is trading 19.6% below its estimated GF Value™ of $15.94.
Key valuation signals for MNICF:
Days Payable: 7.67 (11% below median its 10-year median of 8.63)
GF Value™: $15.94 vs. price of $12.82 (19.6% below fair value)
Industry Position: 88.7% below the Medical Devices & Instruments median (#789 of 795)
No single metric tells the full story. See the MNICF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mani Inc manufactures medical devices and dental instruments. It sells products in four categories: surgical instruments, ophthalmic instruments, suture needles, and dental instruments. Mani's surgical products include instruments such as staplers, vessel knives, and bone saws. Its ophthalmic instruments include a range of knives used during eye surgery and ophthalmic sutures. Mani's suture needles business includes a variety of taper point and cutting eyeless needles, which require suture attachment and sterilization by the customer, as well as stainless-steel eyed needles. The firm's dental instruments include endodontic instruments and accessories, root canal equipment, and finishing and polishing instruments.
98GF Score
Get the complete analysis for MNICF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MNICF has been successfully added to your 
